Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies

References

• Siegel RL, Miller KD, and Jemal A: Cancer statistics, 2017. CA Cancer J Clin 67, 7–30, 2017.
   PubMed Web of Science ®Google Scholar
• Chavez K, Garimella S, and Lipkowitz S: Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis 32, 35–48, 2010.
   PubMedGoogle Scholar
• Ho-Yen CM, Jones JL, and Kermorgant S: The clinical and functional significance of c-Met in breast cancer: a review. Breast Cancer Res 17, 52–62, 2015.
   PubMed Web of Science ®Google Scholar
• Xiao G, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude G, et al.: Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci USA 98, 247–252, 2001.
   PubMed Web of Science ®Google Scholar
• Furlan A, Kherrouche Z, Montagne R, Copin M, and Tulasne D: Thirty years of research on Met receptor to move a biomarker from bench to bedside. Cancer Res 74, 6737–6744, 2014.
   PubMed Web of Science ®Google Scholar
• Newman DJ and Cragg GM: Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79, 629–661, 2016.
   PubMed Web of Science ®Google Scholar
• Maldini M, Montoro P, Hamed A, Mahalel U, Oleszek W, et al.: Strong antioxidant phenolics from Acacia nilotica: Profiling by ESI-MS and qualitative-quantitative determination by LC-ESI-MS. J Pharm Biom Anal 56, 228–239, 2011.
   PubMed Web of Science ®Google Scholar
• Andersen QM and Markham KR: Flavonoids: Chemistry, Biochemistry and Applications. Florida: Taylor and Francis LLC, 2006.
   Google Scholar
• Romagnolo FD and Selmin OI: Flavonoids and cancer prevention: a review of the evidence. J Nutr Geriatr 3, 206–238, 2012.
   Google Scholar
• Altinterim B: Citrus, rutin and on their vein permeability effects. Res J Agr Environ Manage 3, 80–81, 2014.
   Google Scholar
• Alonso-Castro AJ, Domínguez F, and García-Carrancá A: Rutin exerts antitumor effects on nude mice bearing SW480 tumor. Arch Med Res 44:346–351, 2013.
   PubMed Web of Science ®Google Scholar
• Perk A, Shatynska-Mytsyk I, Gerçek Y, Boztaş K, Yazgan M, et al.: Rutin mediated targeting of signaling machinery in cancer cells. Cancer Cell Int 14, 124–128, 2014.
   PubMed Web of Science ®Google Scholar
• Akl MR, Ayoub NM, Mohyeldin MM, Busnena BA, Foudah AI, et al.: Olive phenolics as c-Met inhibitors: (−)-oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models. PLosOne 9, e97622, 2014.
   PubMed Web of Science ®Google Scholar
• Elsayed HE, Akl MR, Ebrahim HY, Sallam AA, Haggag EG, et al.: Discovery, optimization and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk/Paxillin/Rac1 axis. Chem Biol Drug Des 85, 231–243, 2015.
   PubMed Web of Science ®Google Scholar
• Ebrahim HY, Elsayed HE, Mohyeldin MM, Akl MR, Bhattacharjee J, et al.: Norstictic acid inhibits breast cancer cell proliferation, migration, invasion, and in vivo invasive growth through targeting c-Met. Phytother Res 30, 557–566, 2016.
   PubMed Web of Science ®Google Scholar
• RCSB protien data bank. Available online: http://www.rcsb.org/pdb/home/home.do. Accessed April 2016.
   Google Scholar
• Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, et al.: Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 49, 6177–6196, 2006.
   PubMed Web of Science ®Google Scholar
• Eldahshan OA: Isolation and structure elucidation of phenolic compounds of Carob leaves grown in Egypt. Curr Res J Biol Sci 3, 52–55, 2011.
   Google Scholar
• Dawidar AM, Abdel-Mogib M, and El-Naggar ME: Isolation and characterization of Polygonum equisetiforme flavonoids and their acaricidal activity against Tetranychus urticae Koch. Res J Pharm Biol Chem Sci 5,140–148, 2014.
   Google Scholar
• Hari KP, Vijaya BR, Gunasekar D, Marthanda MM, Caux C, et al.: A new coumestan from Tephrosia calophylla. Chem Pharm Bull 51, 194–196, 2003.
   PubMed Web of Science ®Google Scholar
• Krimplstatter R, Ma B, Spitaler R, Ellmerer E, and Zidorn C: 2011. Phenolics from Rhagadiolus stellatus (Asteraceae, Cichorieae). Sci Pharm 79,175–179, 2011.
   PubMedGoogle Scholar
• Felser C and Schimmer O: Flavonoid glycosides from Alchemilla speciosa. Planta Med 65, 668–670, 1999.
   PubMed Web of Science ®Google Scholar
• Bellon SF, Kaplan-Lefko P, Yang Y, Zhang Y, Moriguchi J, et al.: c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. J Biol Chem 283, 2675–2683, 2008.
   PubMed Web of Science ®Google Scholar
• Peterson EA, Teffera Y, Albrecht BK, Bauer D, Bellon S, et al.: Discovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitors. J Med Chem 58, 2417–2430, 2015.
   PubMed Web of Science ®Google Scholar
• Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R, et al.: A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies. BMC Cancer 12, 10–25, 2012.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse J, and Veer L: Breast cancer metastasis: markers and models. Nat Rev Cancer 5, 591–602, 2005.
   PubMed Web of Science ®Google Scholar
• Liang X, Chen C, Zhao Y, and Wang P: Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mo. Biol 596, 467–488, 2010.
   PubMedGoogle Scholar
• Haslam G, Wyatt D, and Kitos P: Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities. Cytotechnology 32, 63–75, 2000.
   PubMed Web of Science ®Google Scholar
• Giordano S, Maffe A, Williams T, Artigiani S, Gual P, et al.: Different point mutations in the c-Met oncogene elicit distinct biological properties. FASEB J 14, 399–406, 2000.
   PubMed Web of Science ®Google Scholar
• Ferreira LG, Dos Santos RN, Oliva G, and Andricopulo AD: Molecular docking and structure-based drug design strategies. Molecules 20, 13384–13421, 2015.
   PubMed Web of Science ®Google Scholar
• Weidner K, Di Cesare S, Sachs M, Brinkmann V, Behrens J, et al.: Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384, 173–176, 1996.
   PubMed Web of Science ®Google Scholar
• Boylea SP, Dobson VL, Duthie SJ, Hinselwood DC, Kyle JA, et al.: Bioavailability and efficiency of rutin as an antioxidant: a human supplementation study. EJCN 54, 774–782, 2000.
   Google Scholar
• Zhang X, Song J, Shi X, Miao S, Li Y et al.: Sci World J 2013, 1–8, 2013.
   Google Scholar
• Ou-yang Z, CaO X, Wei Y, Zhang W, Zhao M et al.: Rev Bras Farmacogn 23, 776–782, 2013.
   Google Scholar
• Park SH, Kim HJ, Yim SH, Kim AR, Tyagi N, et al.: Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates. J Nat Prod 77, 2389–2396, 2014.
   PubMed Web of Science ®Google Scholar